110 filings
Page 4 of 6
8-K
47j8l3662o7287
25 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
myl wd5dmquz
5 Jan 18
Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction
12:00am
8-K
5uf5oec
22 Dec 17
Other Events
12:00am
8-K
qnv6aq5r
12 Oct 17
Other Events
12:00am
8-K
1ehmq1a6v
13 Sep 17
Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to
12:00am
8-K
4n135dq1wx1iwd5xj2d
1 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
qnyok249snpq
8 Aug 17
Departure of Directors or Certain Officers
12:00am
8-K
uubdlug
3 Aug 17
Inotek Pharmaceuticals Corporation Reports Second
12:00am
8-K
lfjp70l2qqydaijch 25
7 Jul 17
Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial
12:00am
8-K
mz3402l
21 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
846lu8q2bmpiprd
10 May 17
Results of Operations and Financial Condition
12:00am
8-K
hysl4k
13 Apr 17
Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combination (FDC) of
12:00am
8-K
wtm75pg1s
16 Mar 17
Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results and Operational Highlights
12:00am
8-K
crds1
3 Jan 17
Inotek AnnouncesTop-line Results forMATrX-1, First Phase 3 Trial ofTrabodenosonfor Glaucoma
12:00am
8-K
8zbiza88ny8l4xru7z7a
29 Nov 16
Regulation FD Disclosure
12:00am
8-K
46n7s3
9 Nov 16
Inotek Pharmaceuticals Corporation Reports Third Quarter 2016 Financial Results and Operational Highlights
12:00am
8-K
pxvofr6sna
7 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
iu8j yd80ud459twlk
29 Sep 16
Inotek Pharmaceuticals Appoints Timothy Barberich to Board of Directors
12:00am
8-K
jba9jemj5d v9fbjam7
24 Aug 16
Other Events
12:00am
8-K
k1hjb rwq
18 Aug 16
Inotek Pharmaceuticals Appoints Patrick Machado, JD, to Board of Directors
12:00am